XML 19 R7.htm IDEA: XBRL DOCUMENT v3.22.4
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Cash Flows from Operating Activities    
Net loss $ (6,336,374) $ (4,529,823)
Adjustments to reconcile net income/(loss) to net cash used by operating activities    
Depreciation and amortization 530,830 247,704
(Gain)/loss on disposal of property and equipment (3,547) 27,170
Noncash lease expense 197,198 196,572
Change in allowance for doubtful accounts 4,510 94,588
Share-based compensation 39,842 45,371
Interest expense paid in equity shares 32,145 821,592
Accrued interest on notes payable 528,100 132,162
Amortization of original issue discounts on notes payable 441,734 325,000
Gain on marketable securities 21
Discharge of Paycheck Protection Program Loans (971,500)
Changes in operating assets and liabilities net of effects from acquisition of subsidiaries:    
Trade receivables (1,541,371) 2,094,282
Trade receivables - related party (383,710) (5,166)
Inventory (116,942) (1,458,595)
Prepaid expenses and other current assets (670,974) (144,745)
Other assets (146,356) (384)
Other liabilities (225,506) (88,266)
Accounts payable (327,945) (726,226)
Accounts payable - related party (99)
Operating lease liabilities (132,963) (104,644)
Deposits from customers 416,523 205,855
Accrued expenses 974,941 (142,307)
Deferred revenue 942,502 (286,261)
Income taxes payable (94,848) (124,823)
Net cash used by operating activities - continuing operations (5,872,310) (3,633,465)
Net cash provided/(used) by operating activities - discontinued operations 2,501,426 (719,237)
Net cash used by operating activities (3,370,884) (4,352,702)
Cash Flows from Investing Activities    
Purchase of property and equipment (571,658) (301,327)
Proceeds from sale of property and equipment 3,547 9,661
Net cash used by investing activities - continuing operations (568,111) (291,666)
Net cash provided by investing activities - discontinued operations 207,329
Net cash provided/(used) by investing activities (360,782) (291,666)
Cash Flows from Financing Activities    
Payments on notes payable (294,370) (326,763)
Payments on bank loans (306,550) (305,990)
Net cash used by financing activities (600,920) (632,753)
Effect of currency translation 229,243 63,228
Net decrease in cash, cash equivalents, and restricted cash (4,332,586) (5,277,121)
Cash, cash equivalents, and restricted cash at beginning of period 11,473,676 17,186,323
Cash, cash equivalents, and restricted cash at end of period 7,370,333 11,972,430
Balance Sheet Accounts Included in Cash, Cash Equivalents, and Restricted Cash    
Cash and equivalents 5,768,610 10,338,978
Restricted cash 1,601,723 1,633,452
Total cash, cash equivalents, and restricted cash 7,370,333 11,972,430
Supplemental Disclosure of Cash Flow Information:    
Cash paid during the period for interest 126,255 126,715
Cash paid during the period for income taxes 94,848 124,823
Supplemental Schedule of Non-Cash Investing and Financing Activities    
Shares issued to pay notes payable 232,145 3,288,071
Investment in right of use asset $ 76,506